What's in Health Ever Bio-Tech Co., Ltd.'s pipeline?

Health Ever Bio-Tech Co., Ltd. has 3 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Health Ever Bio-Tech Co., Ltd.'s portfolio?

Top competitors by shared drug class: Daewon Pharmaceutical Co., Ltd., Pfizer, Avalo Therapeutics, Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., AJU Pharm Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/health-ever-bio-tech-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Health Ever Bio-Tech Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Health Ever Bio-Tech Co., Ltd. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
MCS-2	MCS-2	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
MCS	MCS	phase 3	small molecule	target molecular target	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Daewon Pharmaceutical Co., Ltd. · 2 shared drug classes
Pfizer · 2 shared drug classes
Avalo Therapeutics, Inc. · 2 shared drug classes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 2 shared drug classes
AJU Pharm Co., Ltd. · 2 shared drug classes
Daewoong Pharmaceutical Co. LTD. · 2 shared drug classes
Ahn-Gook Pharmaceuticals Co.,Ltd · 2 shared drug classes
Pharmbio Korea Co., Ltd. · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Health Ever Bio-Tech Co., Ltd.:

Cite this brief

Drug Landscape (2026). Health Ever Bio-Tech Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/health-ever-bio-tech-co-ltd. Accessed 2026-05-17.